Kala Pharmaceuticals Stock Price History
| KALA Stock | USD 6.80 0.23 3.27% |
Below is the normalized historical share price chart for Kala Pharmaceuticals extending back to July 20, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Kala Pharmaceuticals stands at 6.80, as last reported on the 21st of March, with the highest price reaching 6.80 and the lowest price hitting 6.80 during the day.
If you're considering investing in Kala Stock, it is important to understand the factors that can impact its price. Kala Pharmaceuticals appears to be moderately volatile, given 3 months investment horizon. Kala Pharmaceuticals has Sharpe Ratio of 0.0682, which conveys that the firm had a 0.0682 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Kala Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise Kala Pharmaceuticals' Downside Deviation of 7.97, mean deviation of 4.03, and Risk Adjusted Performance of 0.0656 to check out if our risk estimates are consistent with your expectations.
At present, Kala Pharmaceuticals' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 71.2 K, whereas Total Stockholder Equity is forecasted to decline to about 8.2 M. . As of March 21, 2025, Price To Sales Ratio is expected to decline to 16.28. In addition to that, Price Earnings Ratio is expected to decline to -0.49. Kala Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 20th of July 2017 | 200 Day MA 6.6482 | 50 Day MA 7.7322 | Beta (2.20) |
Kala |
Sharpe Ratio = 0.0682
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | KALA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.51 actual daily | 58 58% of assets are less volatile |
Expected Return
| 0.44 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Kala Pharmaceuticals is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kala Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 6.243 | Enterprise Value Ebitda (0.16) | Price Sales 1.157 | Shares Float 2.6 M | Wall Street Target Price 15 |
Kala Pharmaceuticals Stock Price History Chart
There are several ways to analyze Kala Stock price data. The simplest method is using a basic Kala candlestick price chart, which shows Kala Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 7, 2025 | 11.02 |
| Lowest Price | December 20, 2024 | 5.92 |
Kala Pharmaceuticals March 21, 2025 Stock Price Synopsis
Various analyses of Kala Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Kala Stock. It can be used to describe the percentage change in the price of Kala Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Kala Stock.| Kala Pharmaceuticals Price Action Indicator | (0.12) | |
| Kala Pharmaceuticals Price Rate Of Daily Change | 0.97 |
Kala Pharmaceuticals March 21, 2025 Stock Price Analysis
Kala Stock Price History Data
The price series of Kala Pharmaceuticals for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 5.26 with a coefficient of variation of 16.64. The daily prices for the period are spread out with arithmetic mean of 7.43. The median price for the last 90 days is 7.0. The company underwent 1:50 stock split on 21st of October 2022.| Open | High | Low | Close | Volume | ||
03/21/2025 | 7.03 | 6.80 | 6.80 | 6.80 | ||
| 03/20/2025 | 7.03 | 6.99 | 6.57 | 6.80 | 5,937 | |
| 03/19/2025 | 7.25 | 7.27 | 6.91 | 7.03 | 9,199 | |
| 03/18/2025 | 7.30 | 7.30 | 6.91 | 7.21 | 3,980 | |
| 03/17/2025 | 6.55 | 7.30 | 6.55 | 7.00 | 29,438 | |
| 03/14/2025 | 6.77 | 6.88 | 6.51 | 6.55 | 15,854 | |
| 03/13/2025 | 7.02 | 7.02 | 6.73 | 6.75 | 4,427 | |
| 03/12/2025 | 6.75 | 7.13 | 6.75 | 6.95 | 15,145 | |
| 03/11/2025 | 6.61 | 6.90 | 6.49 | 6.90 | 6,218 | |
| 03/10/2025 | 7.13 | 7.13 | 6.66 | 6.78 | 10,838 | |
| 03/07/2025 | 7.01 | 7.08 | 6.83 | 7.05 | 11,728 | |
| 03/06/2025 | 7.31 | 7.37 | 6.74 | 7.17 | 31,585 | |
| 03/05/2025 | 6.93 | 7.97 | 6.93 | 7.57 | 80,184 | |
| 03/04/2025 | 6.73 | 7.00 | 6.44 | 6.92 | 12,978 | |
| 03/03/2025 | 7.19 | 7.19 | 6.66 | 6.99 | 32,569 | |
| 02/28/2025 | 7.17 | 7.17 | 6.61 | 6.93 | 10,771 | |
| 02/27/2025 | 6.86 | 7.15 | 6.60 | 6.97 | 24,582 | |
| 02/26/2025 | 6.45 | 6.75 | 6.41 | 6.71 | 26,468 | |
| 02/25/2025 | 6.50 | 6.75 | 6.48 | 6.57 | 21,920 | |
| 02/24/2025 | 6.65 | 6.70 | 6.39 | 6.64 | 37,679 | |
| 02/21/2025 | 6.95 | 6.95 | 6.55 | 6.64 | 31,165 | |
| 02/20/2025 | 6.80 | 6.99 | 6.50 | 6.84 | 32,985 | |
| 02/19/2025 | 7.25 | 7.61 | 6.61 | 6.77 | 112,485 | |
| 02/18/2025 | 8.38 | 8.38 | 7.21 | 7.22 | 155,159 | |
| 02/14/2025 | 7.84 | 8.65 | 7.71 | 8.38 | 73,682 | |
| 02/13/2025 | 7.40 | 7.86 | 7.01 | 7.76 | 105,045 | |
| 02/12/2025 | 8.02 | 8.99 | 6.97 | 7.44 | 622,222 | |
| 02/11/2025 | 10.07 | 10.88 | 10.00 | 10.88 | 113,723 | |
| 02/10/2025 | 11.20 | 11.20 | 9.83 | 10.30 | 63,405 | |
| 02/07/2025 | 10.48 | 11.20 | 10.48 | 11.02 | 92,002 | |
| 02/06/2025 | 9.55 | 10.79 | 9.55 | 10.73 | 83,183 | |
| 02/05/2025 | 9.15 | 9.80 | 9.15 | 9.70 | 77,723 | |
| 02/04/2025 | 9.25 | 9.66 | 9.25 | 9.30 | 24,103 | |
| 02/03/2025 | 9.07 | 9.40 | 9.00 | 9.22 | 41,029 | |
| 01/31/2025 | 9.57 | 9.59 | 8.87 | 9.20 | 188,070 | |
| 01/30/2025 | 8.85 | 9.74 | 8.34 | 9.48 | 69,002 | |
| 01/29/2025 | 8.70 | 8.90 | 8.34 | 8.83 | 29,481 | |
| 01/28/2025 | 8.35 | 8.95 | 8.04 | 8.77 | 73,095 | |
| 01/27/2025 | 8.00 | 8.44 | 7.84 | 8.37 | 112,510 | |
| 01/24/2025 | 8.25 | 8.30 | 7.92 | 8.11 | 60,932 | |
| 01/23/2025 | 7.62 | 8.35 | 7.61 | 8.15 | 62,078 | |
| 01/22/2025 | 7.65 | 7.85 | 7.51 | 7.69 | 75,966 | |
| 01/21/2025 | 7.30 | 7.85 | 7.00 | 7.68 | 140,856 | |
| 01/17/2025 | 7.01 | 7.60 | 7.01 | 7.25 | 17,502 | |
| 01/16/2025 | 7.15 | 7.24 | 6.96 | 7.01 | 7,576 | |
| 01/15/2025 | 6.50 | 7.19 | 6.50 | 7.13 | 13,759 | |
| 01/14/2025 | 6.62 | 6.74 | 6.51 | 6.65 | 20,121 | |
| 01/13/2025 | 6.71 | 6.85 | 6.55 | 6.55 | 15,797 | |
| 01/10/2025 | 6.80 | 7.12 | 6.61 | 6.81 | 36,908 | |
| 01/08/2025 | 7.49 | 7.70 | 6.76 | 6.82 | 66,008 | |
| 01/07/2025 | 7.65 | 7.84 | 7.41 | 7.69 | 45,377 | |
| 01/06/2025 | 8.01 | 8.14 | 7.45 | 7.53 | 79,997 | |
| 01/03/2025 | 7.80 | 8.39 | 7.80 | 7.93 | 114,431 | |
| 01/02/2025 | 7.39 | 8.79 | 7.39 | 7.71 | 180,419 | |
| 12/31/2024 | 6.89 | 7.20 | 6.52 | 6.94 | 33,197 | |
| 12/30/2024 | 7.14 | 7.21 | 6.81 | 6.87 | 34,552 | |
| 12/27/2024 | 7.05 | 7.19 | 6.83 | 6.98 | 26,671 | |
| 12/26/2024 | 6.33 | 7.32 | 6.24 | 6.94 | 49,641 | |
| 12/24/2024 | 6.04 | 6.28 | 6.04 | 6.24 | 38,007 | |
| 12/23/2024 | 5.90 | 6.00 | 5.80 | 6.00 | 13,156 | |
| 12/20/2024 | 5.78 | 6.04 | 5.75 | 5.92 | 12,938 |
About Kala Pharmaceuticals Stock history
Kala Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kala is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kala Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kala Pharmaceuticals stock prices may prove useful in developing a viable investing in Kala Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2.8 M | 2.9 M | |
| Net Loss | -40.3 M | -42.4 M |
Kala Pharmaceuticals Quarterly Net Working Capital |
|
Kala Pharmaceuticals Stock Technical Analysis
Kala Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Kala Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Kala Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Kala Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kala to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0656 | |||
| Jensen Alpha | 0.4917 | |||
| Total Risk Alpha | 0.9174 | |||
| Sortino Ratio | 0.0584 | |||
| Treynor Ratio | 0.2901 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Kala Stock analysis
When running Kala Pharmaceuticals' price analysis, check to measure Kala Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kala Pharmaceuticals is operating at the current time. Most of Kala Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kala Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kala Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kala Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |